Form 4 for BNTC Benitec Biopharma Inc.
Accepted 2024-12-05 00:00:00 ET · period of report 2024-12-03 · accession 0000899140-24-001318 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-12-05 | 2024-12-03 | BNTC | SUVRETTA CAPITAL MANAGEMENT, LLC | Dir, 10% | P - Purchase | $9.60 | +42.0K | 7.96M | +0.5% | +$403.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.0001 per share | 2024-12-03 | P | A | 4,810 | $9.60 | 955,124 | I See footnotes | — | — | (F3) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. |
| 2 | Common | Common stock, par value $0.0001 per share | 2024-12-03 | P | A | 37,190 | $9.60 | 7,957,365 | I See footnotes | — | — | (F2) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. |